A new technology that delivers two halves of a gene separately could enable gene therapy treatments of muscular dystrophies.

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

Jason Farned and his team at the San Gabriel Valley Mosquito and Vector Control District had spent years preparing for the ...

In 2014, he founded VectorBuilder, a revolutionary online platform for vector design and ordering that has streamlined research workflows for hundreds of thousands of life science laboratories ...

In relation to the acquisition of Vector’s Liquigas shares ... has been undertaken by University of Auckland Masters student Aman Tyagi as part of a data science industry project guided by mentors ...

Effective dengue prevention requires a combination of vector control and vaccination efforts, a group of physicians said ...

Marcel Imwinkelried, Chief Executive Officer Siegfried: “Aligned with Siegfried's strategy EVOLVE+, the new lab facility marks a key milestone in DINAMIQS' journey to becoming the leading CDMO in the ...

Singapore’s Agency for Science, Technology and Research Infectious Diseases ... development of innovative technologies in these key ID areas: respiratory diseases, vector-borne diseases, and ...